vs
Side-by-side financial comparison of INNO HOLDINGS INC. (INHD) and Korro Bio, Inc. (KRRO). Click either name above to swap in a different company.
INNO HOLDINGS INC. is the larger business by last-quarter revenue ($1.5M vs $1.3M, roughly 1.1× Korro Bio, Inc.). On growth, INNO HOLDINGS INC. posted the faster year-over-year revenue change (635.6% vs -43.1%).
INNOvative Retail BV, is an upmarket Belgian department store chain that operates sixteen branches around Belgium.
Korro Bio, Inc. is a clinical-stage biotechnology company focused on developing innovative RNA editing therapies for rare and severe genetic diseases. It leverages its proprietary oligonucleotide platform to target disease-causing mutations, with core pipelines covering ophthalmology, respiratory and neuromuscular disorder segments, striving to address unmet medical needs for global patients.
INHD vs KRRO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5M | $1.3M |
| Net Profit | $-28.6K | — |
| Gross Margin | 5.1% | — |
| Operating Margin | -33.4% | — |
| Net Margin | -2.0% | — |
| Revenue YoY | 635.6% | -43.1% |
| Net Profit YoY | 95.3% | -136.1% |
| EPS (diluted) | $-0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5M | $1.3M | ||
| Q3 25 | $1.1M | $1.1M | ||
| Q2 25 | $1.1M | $1.5M | ||
| Q1 25 | $478.1K | $2.5M | ||
| Q4 24 | $196.0K | — | ||
| Q3 24 | $490.0K | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | $183.2K | $0 |
| Q4 25 | $-28.6K | — | ||
| Q3 25 | $-1.3M | $-18.1M | ||
| Q2 25 | $-1.5M | $-25.8M | ||
| Q1 25 | $-3.6M | $-23.4M | ||
| Q4 24 | $-603.7K | — | ||
| Q3 24 | $-287.2K | $-21.0M | ||
| Q2 24 | — | $-21.8M | ||
| Q1 24 | $-1.1M | $-19.6M |
| Q4 25 | 5.1% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | -1.5% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -33.4% | — | ||
| Q3 25 | -89.7% | -1764.9% | ||
| Q2 25 | -143.7% | -1863.2% | ||
| Q1 25 | -286.4% | -981.2% | ||
| Q4 24 | -233.7% | — | ||
| Q3 24 | 87.7% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -150.9% | — |
| Q4 25 | -2.0% | — | ||
| Q3 25 | -120.5% | -1657.0% | ||
| Q2 25 | -142.4% | -1765.1% | ||
| Q1 25 | -757.3% | -917.1% | ||
| Q4 24 | -308.0% | — | ||
| Q3 24 | -58.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -578.9% | — |
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $5.03 | $-1.92 | ||
| Q2 25 | $-0.30 | $-2.74 | ||
| Q1 25 | $-0.83 | $-2.49 | ||
| Q4 24 | $-5.21 | — | ||
| Q3 24 | $-0.14 | $-2.26 | ||
| Q2 24 | — | $-2.43 | ||
| Q1 24 | $-0.51 | $-2.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.1M | $75.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $47.2M | $51.4M |
| Total Assets | $47.3M | $113.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.1M | $75.2M | ||
| Q3 25 | $10.1M | $92.5M | ||
| Q2 25 | $4.4M | $96.4M | ||
| Q1 25 | $3.9M | $115.0M | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $1.1M | $137.0M | ||
| Q2 24 | — | $157.4M | ||
| Q1 24 | $4.0M | $138.8M |
| Q4 25 | $47.2M | $51.4M | ||
| Q3 25 | $15.2M | $99.0M | ||
| Q2 25 | $8.0M | $115.1M | ||
| Q1 25 | $7.1M | $139.0M | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $2.8M | $179.6M | ||
| Q2 24 | — | $198.1M | ||
| Q1 24 | $4.1M | $151.4M |
| Q4 25 | $47.3M | $113.5M | ||
| Q3 25 | $16.0M | $161.6M | ||
| Q2 25 | $8.8M | $180.4M | ||
| Q1 25 | $7.3M | $202.2M | ||
| Q4 24 | $10.7M | — | ||
| Q3 24 | $4.2M | $243.5M | ||
| Q2 24 | — | $249.6M | ||
| Q1 24 | $7.1M | $198.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.0M | $-78.6M |
| Free Cash FlowOCF − Capex | — | $-79.1M |
| FCF MarginFCF / Revenue | — | -6120.7% |
| Capex IntensityCapex / Revenue | — | 40.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-140.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.0M | $-78.6M | ||
| Q3 25 | $-1.0M | $-17.2M | ||
| Q2 25 | $-594.8K | $-19.2M | ||
| Q1 25 | $-1.0M | $-24.5M | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $-660.2K | $-16.1M | ||
| Q2 24 | — | $-14.6M | ||
| Q1 24 | $-2.9M | $-21.9M |
| Q4 25 | — | $-79.1M | ||
| Q3 25 | — | $-17.4M | ||
| Q2 25 | — | $-19.4M | ||
| Q1 25 | — | $-24.6M | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $-795.1K | $-21.0M | ||
| Q2 24 | — | $-20.6M | ||
| Q1 24 | $-3.2M | $-27.5M |
| Q4 25 | — | -6120.7% | ||
| Q3 25 | — | -1592.1% | ||
| Q2 25 | — | -1326.6% | ||
| Q1 25 | — | -963.6% | ||
| Q4 24 | -1083.3% | — | ||
| Q3 24 | -162.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1720.9% | — |
| Q4 25 | — | 40.1% | ||
| Q3 25 | — | 16.1% | ||
| Q2 25 | — | 9.6% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | 13.7% | — | ||
| Q3 24 | 27.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 118.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
